Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Mauve Factor re-identified as 2,4-Dimethyl-3-ethylpyrrole and its Sedative Effect on the CNS

Abstract

Irvine1 and Hoffer and Mahon2 reported on the occurrence of a compound giving a characteristic mauve colour with Ehrlich's reagent on paper. The significance of this metabolite is that it occurs with greater frequency in psychotic individuals. This finding has been confirmed by several investigators3–5. Ellman et al.6, however, reported that a metabolite apparently identical to the one in question may be derived from phenothiazines and occurs in the urine of patients on phenothiazine therapy. Recently, Irvine7 has identified the mauve factor as 2,4-dimethyl-3-ethylpyrrole on the basis of chromatographic and mass spectral studies. This report is concerned with the identity of the mauve factor, a critique of various isolation procedures used by different investigators and its pharmacological action on the central nervous system (CNS). The possible CNS effect is important because several laboratories have postulated a metabolic product in the schizophrenic which may be stimulant and hallucinogenic.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Irvine, D. G., J. Neuropsychiat., 2, 292 (1961).

    CAS  PubMed  Google Scholar 

  2. Hoffer, A., and Mahon, M., J. Neuropsychiat., 2, 331 (1961).

    CAS  PubMed  Google Scholar 

  3. Sohler, A., Renz, R. H., Smith, S., and Kaufman, jun., J., Intern. J. Neuropsychiat., 3, 327 (1967).

    CAS  Google Scholar 

  4. O'Reilly, P. O., Ernest, M., and Hughes, G., Brit. J. Psychiat., 111, 741 (1965).

    Article  CAS  PubMed  Google Scholar 

  5. O'Reilly, P. O., Hughes, G., Russell, S., and Ernest, M., Dis. Nerv. Syst., 26, 562 (1965).

    CAS  PubMed  Google Scholar 

  6. Ellman, G. L., Jones, R. T., and Rychert, R. C., Amer. J. Psychiat., 125, 849 (1968).

    Article  CAS  PubMed  Google Scholar 

  7. Irvine, D. G., Bayne, W., Miyashita, H., and Majer, J. R., Nature, 224, 811 (1969).

    Article  ADS  CAS  PubMed  Google Scholar 

  8. Forrest, F. M., Forrest, I. S., and Mason, A. S., Amer. J. Psychiat., 118, 300 (1961).

    Article  CAS  PubMed  Google Scholar 

  9. Goldstein, L., and Beck, R. A., in Internat. Rev. Neurobiol. (edit. by Pfeiffer, C. C., and Smythies, J. R.), 8, 266 (1965).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

SOHLER, A., BECK, R. & NOVAL, J. Mauve Factor re-identified as 2,4-Dimethyl-3-ethylpyrrole and its Sedative Effect on the CNS. Nature 228, 1318–1320 (1970). https://doi.org/10.1038/2281318a0

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1038/2281318a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing